Emergent BioSolutions Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Good morning, everyone. My name is Jess Fye. I'm a senior biotech analyst with JPMorgan. And welcome to the 40th Annual JPMorgan Healthcare Conference. Pleased to be kicking off the day with Emergent BioSolutions. We're joined by the company's CEO, Bob Kramer. I'm going to pass it over to him for a presentation, and then we'll turn to Q&A after that. There's a blue Ask a Question button on your screen. So if you want to send me a question on the portal to ask during the Q&A session, please use it, and you can hear those after the presentation.
With that, let me turn it over to Bob.
Thanks, Jess. Good morning, everyone. Thanks for joining the call. And Jess and JPMorgan, thanks for the opportunity to present and participate in the health care conference this year. Look forward to a great couple of days. So for the benefit of the folks on the call, just a couple of reminders. First of
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
